(Q77932331)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Design of a variant of vascular endothelial growth factor-A (VEGF-A) antagonizing KDR/Flk-1 and Flt-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

Nicolette Lubsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Margarethe van Altena

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Matthias Clauss

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Martine Deckers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Georg Breier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Dirk Ruiter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Robert de Waal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

473-481

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11950904%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.3780440

9 December 2019

exact match

0 references

cites work

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Involvement of loop 2 of platelet-derived growth factor-AA and -BB in receptor binding

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

1 reference

7 January 2021

A family of angiogenic peptides

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Targetting VEGF in anti-angiogenic and anti-tumour therapy: where are we now?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Angiozyme: a novel angiogenesis inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780440

7 January 2021